Gilead Wins $6 Million Deal to Distribute HIV Drug It Donated

Sept. 27, 2019, 10:05 PM

The HIV prevention drug that Gilead Sciences donated to the U.S. will hit the streets in the next two months after the company won a contract to distribute its own gift.

A deal struck between the Department of Health and Human Services and Gilead Sept. 27 will accelerate plans to distribute the HIV prevention pills the drugmaker donated to support the Trump administration’s plan to end the HIV epidemic. The pills will be made available to health centers using Gilead’s existing distribution network.

The six-month contract awards Gilead $6 million to put Truvada into the hands of 4,250 uninsured patients,...

To read the full article log in.

Learn more about a Bloomberg Law subscription.